A trial of emepronium bromide for the treatment of urinary incontinence in the elderly mentally ill.
A double-blind controlled trial was conducted of emepronium bromide against placebo in elderly mentally ill patients in hospital with urinary incontinence. No significant difference was found between 200 mg emepronium bromide 3-times daily and placebo in treating day-time or nocturnal urinary incontinence for patients suffering from chronic organic brain syndrome or from chronic functional psychiatric illness.
D000368:Aged; D002986:Clinical Trials as Topic; D003704:Dementia / Q000150:complications; D004629:Emepronium / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D019965:Neurocognitive Disorders / Q000150:complications; D000644:Quaternary Ammonium Compounds / Q000627:therapeutic use*; D014549:Urinary Incontinence / Q000188:drug therapy*
D000644:Quaternary Ammonium Compounds; D004629:Emepronium